Cargando…
Estimation of metabolite T(1) relaxation times using tissue specific analysis, signal averaging and bootstrapping from magnetic resonance spectroscopic imaging data
Object A novel method of estimating metabolite T(1) relaxation times using MR spectroscopic imaging (MRSI) is proposed. As opposed to conventional single-voxel metabolite T(1) estimation methods, this method investigates regional and gray matter (GM)/white matter (WM) differences in metabolite T(1)...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2798973/ https://www.ncbi.nlm.nih.gov/pubmed/17602253 http://dx.doi.org/10.1007/s10334-007-0076-0 |
Sumario: | Object A novel method of estimating metabolite T(1) relaxation times using MR spectroscopic imaging (MRSI) is proposed. As opposed to conventional single-voxel metabolite T(1) estimation methods, this method investigates regional and gray matter (GM)/white matter (WM) differences in metabolite T(1) by taking advantage of the spatial distribution information provided by MRSI. Material and methods The method, validated by Monte Carlo studies, involves a voxel averaging to preserve the GM/WM distribution, a non-linear least squares fit of the metabolite T(1) and an estimation of its standard error by bootstrapping. It was applied in vivo to estimate the T(1) of N-acetyl compounds (NAA), choline, creatine and myo-inositol in eight normal volunteers, at 1.5 T, using a short echo time 2D-MRSI slice located above the ventricles. Results WM-T(1,NAA) was significantly (P < 0.05) longer in anterior regions compared to posterior regions of the brain. The anterior region showed a trend of a longer WM T(1) compared to GM for NAA, creatine and myo-Inositol. Lastly, accounting for the bootstrapped standard error estimate in a group mean T(1) calculation yielded a more accurate T(1) estimation. Conclusion The method successfully measured in vivo metabolite T(1) using MRSI and can now be applied to diseased brain. |
---|